Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Immune cells of myeloid lineage are encountered in the Alzheimer’s disease (AD) brain, where they cluster around amyloid-β plaques. However, assigning functional roles to myeloid cell subtypes has been problematic, and the potential for peripheral myeloid cells to alleviate AD pathology remains unclear. Therefore, we asked whether replacement of brain-resident myeloid cells with peripheral monocytes alters amyloid deposition in two mouse models of cerebral β-amyloidosis (APP23 and APPPS1). Interestingly, early after repopulation, infiltrating monocytes neither clustered around plaques nor showed Trem2 expression. However, with increasing time in the brain, infiltrating monocytes became plaque associated and also Trem2 positive. Strikingly, however, monocyte repopulation for up to 6 mo did not modify amyloid load in either model, independent of the stage of pathology at the time of repopulation. Our results argue against a long-term role of peripheral monocytes that is sufficiently distinct from microglial function to modify cerebral β-amyloidosis. Therefore, myeloid replacement by itself is not likely to be effective as a therapeutic approach for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“consistent with several studies showing that recruited myeloid cells are not as competent at restricting fAβ as resident microglia [48–50].”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [50]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“two recent studies showed that brain-engrafted bone marrow–derived cells either do not acquire microglial functions or do so only after a long time (202, 203).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [202]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 1×
“These genes are expressed by myeloid cells within the brain and include, for example, CD33, CR1, and Trem2 (Guerreiro et al., 2013; Lambert et al., 2013).”
BackgroundTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 13×
“Furthermore, recent data indicate that infiltrating monocytes rather than resident microglia express Trem2 (Jay et al., 2015), which would further substantiate a significant role of peripheral myeloid cells in AD pathogenesis.”
BackgroundInfluentialTissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968 · cited 2×
“A recent study used a CSF1-receptor inhibitor to deplete resident microglia and found that, in contrast to the HSVTK model, myeloid repopulation occurred from a brain-resident microglial progenitor (Elmore et al., 2014).”
MethodResultTREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 1×
“If so, the replacement of brain-resident myeloid cells with peripheral monocytes could be of therapeutic value for the treatment of AD, as indicated for other neurological disorders (Cartier et al., 2009; Derecki et al., 2012).”
BackgroundTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Self-citationAlzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Cited by
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Innate immune memory in the brain shapes neurological disease hallmarks
Wendeln, A.-C., Degenhardt, K., Kaurani, L., Gertig, M., Ulas, T., Jain, G., Wagner, J., Häsler, L. M., Wild, K., Skodras, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0023-4 · Cited by 956
Self-citationTREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840
“Consistent with the predominant impact of brain-resident microglia in the response to amyloid, two recent studies showed that in a transgenic mouse model of Aβ deposition in which microglia are depleted after intracranial injection of gangliocyclovir and replaced with infiltrating monocytes, the infiltrating cells co-…”
BackgroundThe blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
“Therefore, soluble A β oligomers induce the expression of vascular adhesion molecules, which may promote leukocyte adhesion and transmigration during AD.”
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Bachiller, S., Jiménez-Ferrer, I., Paulus, A., Yang, Y., Swanberg, M., Deierborg, T., & Boza-Serrano, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00488 · Cited by 707
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
Self-citationInterplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
Shi, Y., & Holtzman, D. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0051-1 · Cited by 595
TREM2, microglia, and neurodegenerative diseases
Yeh, F. L., Hansen, D. V., & Sheng, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.008 · Cited by 440
Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus
Bettcher, B. M., Tansey, M. G., Dorothée, G., & Heneka, M. T. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00549-x · Cited by 427
TREM2 in Neurodegenerative Diseases
Jay, T. R., von Saucken, V. E., & Landreth, G. E. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0197-5 · Cited by 427
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Colonna, M., & Wang, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.7 · Cited by 418
Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models
Spangenberg, E. E., & Green, K. N. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.003 · Cited by 352
Elucidating the Role of TREM2 in Alzheimer’s Disease
Ulrich, J. D., Ulland, T. K., Colonna, M., & Holtzman, D. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.042 · Cited by 325
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
Bairamian, D., Sha, S., Rolhion, N., Sokol, H., Dorothée, G., Lemere, C. A., & Krantic, S. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00522-2 · Cited by 314
The identity and function of microglia in neurodegeneration
Song, W. M., & Colonna, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0212-1 · Cited by 308
Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes
Zuroff, L., Daley, D., Black, K. L., & Koronyo-Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 275
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Ardura-Fabregat, A., Boddeke, E. W. G. M., Boza-Serrano, A., Brioschi, S., Castro-Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0483-3 · Cited by 233
Peripheral immune system in aging and Alzheimer’s disease
Cao, W., & Zheng, H. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0284-2 · Cited by 214
Efficient Strategies for Microglia Replacement in the Central Nervous System
Xu, Z., Rao, Y., Huang, Y., Zhou, T., Feng, R., Xiong, S., Yuan, T.-F., Qin, S., Lu, Y., Zhou, X., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108041 · Cited by 172
NETosis in Alzheimer’s Disease
Pietronigro, E. C., Della Bianca, V., Zenaro, E., & Constantin, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00211 · Cited by 175
Microglia versus Monocytes: Distinct Roles in Degenerative Diseases of the Retina
Yu, C., Roubeix, C., Sennlaub, F., & Saban, D. R. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.03.012 · Cited by 168
MacPherson, K. P., Sompol, P., Kannarkat, G. T., Chang, J., Sniffen, L., Wildner, M. E., Norris, C. M., & Tansey, M. G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.010 · Cited by 158
TREM2 Function in Alzheimer’s Disease and Neurodegeneration
Ulrich, J. D., & Holtzman, D. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00313 · Cited by 154
Zhang, Y., Zhao, L., Wang, X., Ma, W., Lazere, A., Qian, H.-H., Zhang, J., Abu-Asab, M., Fariss, R. N., Roger, J. E., et al. (2018) · Science Advances · doi:10.1126/sciadv.aap8492 · Cited by 149
A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer’s models
Rentsendorj, A., Sheyn, J., Fuchs, D.-T., Daley, D., Salumbides, B. C., Schubloom, H. E., Hart, N. J., Li, S., Hayden, E. Y., Teplow, D. B., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.019 · Cited by 141
Microglia-Mediated Neuroprotection, TREM2, and Alzheimer’s Disease: Evidence From Optical Imaging
Condello, C., Yuan, P., & Grutzendler, J. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.007 · Cited by 131
“However, single-cell RNA sequencing (15) or immunohistochemistry (38,44) has shown that TREM2 signaling appears to be activated only after microglia have fully engaged around plaques.”
Piirainen, S., Youssef, A. M., Song, C., Kalueff, A. V., Landreth, G. E., Malm, T., & Tian, L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.046 · Cited by 136
Targeting innate immunity for neurodegenerative disorders of the central nervous system
Andreasson, K. I., Bachstetter, A. D., Colonna, M., Ginhoux, F., Holmes, C., Lamb, B., Landreth, G., Lee, D. C., Low, D., Lynch, M. A., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13667 · Cited by 126
Differential contribution of microglia and monocytes in neurodegenerative diseases
Baufeld, C., O’Loughlin, E., Calcagno, N., Madore, C., & Butovsky, O. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 123
Inflammatory mechanisms in neurodegeneration
Nichols, M. R., St‐Pierre, M., Wendeln, A., Makoni, N. J., Gouwens, L. K., Garrad, E. C., Sohrabi, M., Neher, J. J., Tremblay, M., & Combs, C. K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14674 · Cited by 121
Self-citationImpact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice
Prokop, S., Miller, K. R., Drost, N., Handrick, S., Mathur, V., Luo, J., Wegner, A., Wyss-Coray, T., & Heppner, F. L. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150479 · Cited by 116
A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer’s disease
Yoo, Y., Neumayer, G., Shibuya, Y., Mader, M. M.-D., & Wernig, M. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.07.006 · Cited by 109
Systemic and CNS Inflammation Crosstalk: Implications for Alzheimer’s Disease
Paouri, E., & Georgopoulos, S. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190321154618 · Cited by 110
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Wagner, J., Degenhardt, K., Veit, M., Louros, N., Konstantoulea, K., Skodras, A., Wild, K., Liu, P., Obermüller, U., Bansal, V., et al. (2022) · Nature · doi:10.1038/s41586-022-05440-3 · Cited by 110
Self-citationMöhle, L., Israel, N., Paarmann, K., Krohn, M., Pietkiewicz, S., Müller, A., Lavrik, I. N., Buguliskis, J. S., Schott, B. H., Schlüter, D., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0293-8 · Cited by 103
Zuo, Z., Qi, F., Yang, J., Wang, X., Wu, Y., Wen, Y., Yuan, Q., Zou, J., Guo, K., & Yao, Z. B. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.001 · Cited by 80
Peripheral and central neuroimmune mechanisms in Alzheimer’s disease pathogenesis
Zhang, S., Gao, Y., Zhao, Y., Huang, T. Y., Zheng, Q., & Wang, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00812-5 · Cited by 78
Rivera-Escalera, F., Pinney, J. J., Owlett, L., Ahmed, H., Thakar, J., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1645-7 · Cited by 75
The role of the immune system in driving neuroinflammation
Ní Chasaide, C., & Lynch, M. A. (2020) · Brain and Neuroscience Advances · doi:10.1177/2398212819901082 · Cited by 72
Koronyo-Hamaoui, M., Sheyn, J., Hayden, E. Y., Li, S., Fuchs, D.-T., Regis, G. C., Lopes, D. H. J., Black, K. L., Bernstein, K. E., Teplow, D. B., et al. (2020) · Brain · doi:10.1093/brain/awz364 · Cited by 70
Xue, F., & Du, H. (2021) · Cells · doi:10.3390/cells10020321 · Cited by 67
Chen, Y., Lad, E. M., Mathew, R., Shiraki, N., Littleton, S., Chen, Y., Hou, J., Schlepckow, K., Degan, S., Chew, L. A., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231011 · Cited by 76
Muñoz-Castro, C., Mejias-Ortega, M., Sanchez-Mejias, E., Navarro, V., Trujillo-Estrada, L., Jimenez, S., Garcia-Leon, J. A., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Romero-Molina, C., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01530-z · Cited by 66
“In fact, microglial depletion strategies induced a rapid repopulation by peripherally-derived macrophages [9, 21, 31, 41, 44, 58].”
BackgroundMicroglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Casali, B. T., & Reed-Geaghan, E. G. (2021) · Cells · doi:10.3390/cells10040957 · Cited by 78
Manji, Z., Rojas, A., Wang, W., Dingledine, R., Varvel, N. H., & Ganesh, T. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180678 · Cited by 60
Self-citationImpact of aging immune system on neurodegeneration and potential immunotherapies
Liang, Z., Zhao, Y., Ruan, L., Zhu, L., Jin, K., Zhuge, Q., Su, D., & Zhao, Y. L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.006 · Cited by 67
Recent advances in the understanding of microglial development and homeostasis
Low, D., & Ginhoux, F. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.01.004 · Cited by 54
Li, S., Hayden, E. Y., Garcia, V. J., Fuchs, D.-T., Sheyn, J., Daley, D. A., Rentsendorj, A., Torbati, T., Black, K. L., Rutishauser, U., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00049 · Cited by 51
Shi, M., Chu, F., Zhu, F., & Zhu, J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03003-5 · Cited by 54
Hohsfield, L. A., Najafi, A. R., Ghorbanian, Y., Soni, N., Crapser, J., Figueroa Velez, D. X., Jiang, S., Royer, S. E., Kim, S. J., Henningfield, C. M., et al. (2021) · eLife · doi:10.7554/elife.66738 · Cited by 48
TREM2 expression and amyloid‐beta phagocytosis in Alzheimer's disease
La Rosa, F., Agostini, S., Piancone, F., Marventano, I., Hernis, A., Fenoglio, C., Galimberti, D., Scarpini, E., Saresella, M., & Clerici, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108626 · Cited by 50
Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer’s pathology
Zhang, Z., Takeda‐Uchimura, Y., Foyez, T., Ohtake‐Niimi, S., Narentuya, Akatsu, H., Nishitsuji, K., Michikawa, M., Wyss‐Coray, T., Kadomatsu, K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615036114 · Cited by 53
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 51
Singh, A. K., Mishra, G., Maurya, A., Awasthi, R., Kumari, K., Thakur, A., Rai, A., Rai, G. K., Sharma, B., Kulkarni, G. T., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190903102822 · Cited by 48
Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives
Liu, Z., Liu, M., Xiong, Y., Wang, Y., & Bu, X. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13864 · Cited by 39
Chen, D., Wang, C., Chen, X., Li, J., Chen, S., Li, Y., Ma, F., Li, T., Zou, M., Li, X., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ads6111 · Cited by 43
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2844-6 · Cited by 42
Kajiwara, Y., McKenzie, A. T., Dorr, N. P., Sosa, M. A. G., Elder, G. A., Schmeidler, J., Dickstein, D. L., Bozdagi, O., Zhang, B., & Buxbaum, J. D. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw265 · Cited by 45
Monocytes in the Peripheral Clearance of Amyloid-β and Alzheimer’s Disease
Guo, H., Zhao, Z., Zhang, R., Chen, P., Zhang, X., Cheng, F., & Gou, X. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-181177 · Cited by 36
Regulation of Microglia Identity from an Epigenetic and Transcriptomic Point of View
Eggen, B. J. L., Boddeke, E. W. G. M., & Kooistra, S. M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.010 · Cited by 34
Costello, D. A., Keenan, K., McManus, R. M., Falvey, A., & Lynch, M. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.001 · Cited by 33
Lessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies
Lund, H., Pieber, M., & Harris, R. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00234 · Cited by 28
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Immune dysfunction in Alzheimer disease
Butovsky, O., Rosenzweig, N., Kleemann, K. L., Jorfi, M., Kuchroo, V. K., Tanzi, R. E., & Weiner, H. L. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00997-0 · Cited by 48
Kuroda, E., Nishimura, K., Kawanishi, S., Sueyoshi, M., Ueno, F., Toji, Y., Abo, N., Konishi, T., Harada, K., Satake, S., et al. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.004 · Cited by 24
Evolving Models and Tools for Microglial Studies in the Central Nervous System
Zhang, Y., & Cui, D. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00706-8 · Cited by 25
Neuronal Ceroid Lipofuscinosis—Concepts, Classification, and Avenues for Therapy
Zhang, Y., Du, B., Zou, M., Peng, B., & Rao, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70261 · Cited by 35
Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease
Salminen, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104919 · Cited by 25
Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders
Rao, Y., & Peng, B. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.02.025 · Cited by 20
The Immune System as a Therapeutic Target for Alzheimer’s Disease
Zieneldien, T., Kim, J., Sawmiller, D. R., & Cao, C. (2022) · Life · doi:10.3390/life12091440 · Cited by 24
Ayyubova, G. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15914 · Cited by 23
Kuroda, E., Takata, K., Nishimura, K., Oka, H., Sueyoshi, M., Aitani, M., Kouda, A., Satake, S., Shima, C., Toda, Y., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190974 · Cited by 20
Niche-specific therapeutic targeting of myeloid cells in the central nervous system
Frosch, M., & Prinz, M. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.016 · Cited by 20
Toomey, C. E., Heywood, W., Benson, B. C., Packham, G., Mills, K. A., & Lashley, T. (2020) · Brain Pathology · doi:10.1111/bpa.12842 · Cited by 18
Ye, X., Chen, J., Pan, J., Wu, Q., Wang, Y., Lu, M., Zhang, C., Zhang, Z., Ma, M., Zhu, J., et al. (2022) · Immunological Investigations · doi:10.1080/08820139.2022.2136525 · Cited by 18
Bone Marrow‐Derived GCA+ Immune Cells Drive Alzheimer's Disease Progression
Zhou, R., Wang, L., Chen, L., Xu, F., Zhou, R., Peng, X. F., Wen, J., Huang, Y., & Zhou, H. (2023) · Advanced Science · doi:10.1002/advs.202303402 · Cited by 20
Multitasking Microglia and Alzheimer’s Disease: Diversity, Tools and Therapeutic Targets
Grubman, A., Kanninen, K. M., & Malm, T. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0825-5 · Cited by 16
Exploring microglial replacement: From disease models to clinical translation
Zhou, K., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.011 · Cited by 13
Neuroinflammation and Disease: Pathways and Opportunities
Hoffman, O., Varvel, N. H., Roopra, A., & Dingledine, R. J. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-062124-043519 · Cited by 15
Self-citationLiu, Z., Bai, Y.-D., Yu, Z., Li, H., Liu, J., Tan, C., Zeng, G., Tu, Y., Sun, P., Jia, Y., et al. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01077-y · Cited by 18
Murray, P. J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.11.004 · Cited by 11
Yu, Z., Liu, J., Liu, Z., Liu, X., Tuo, J., Li, J., Tu, Y., Tan, Q., Ma, Y., Bai, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14402 · Cited by 13
Woo, M. S., Nilsson, J., Therriault, J., Rahmouni, N., Brinkmalm, A., Benedet, A. L., Ashton, N. J., Macedo, A. C., Servaes, S., Wang, Y.-T., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02962-z · Cited by 10
Repopulation of microglia and its implications for CNS disorders: Insights from the single-cell era
Chen, C., Qiao, G., Tang, D., Xu, F., Dong, J., Zhang, J., & Jin, B. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107066 · Cited by 8
Peripheral macrophages not ADept at amyloid clearance
Jay, T. R., Lamb, B. T., & Landreth, G. E. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.21211insight5 · Cited by 6
The Amyloid-beta rich CNS environment alters myeloid cell functionality independent of their origin
Drost, N., Houtman, J., Cseresnyés, Z., Niesner, R. A., Rinnenthal, J.-L., Miller, K. R., Prokop, S., & Heppner, F. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-63989-3 · Cited by 5
Macrophages in age-related macular degeneration: a narrative review
Khademi, S., Yu, Z., Zhou, T., Song, B., & Xu, Z. (2024) · Aging advances. · doi:10.4103/agingadv.agingadv-d-24-00007 · Cited by 5
Context-dependent regulatory variants in Alzheimer’s diseasePreprint
Chen, Z., Liu, Y., Brown, A. R., Sestili, H. H., Ramamurthy, E., Xiong, X., Prokopenko, D., Phan, B. N., Gadey, L., van de Weerd, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.11.659973 · Cited by 3
Functional Analysis of Brain-Engrafted Monocytes After Microglia Ablation in Mouse Models
Varvel, N. H., Ransohoff, R. M., & Neher, J. J. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9658-2_22 · Cited by 2
Self-citationNeuroinflammation in Age-Related Neurodegenerative Diseases
MacPherson, K. P., Rodrigues, M. E. D. S., Cintron, A. F., & Tansey, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00016-x · Cited by 3
Therapeutic Strategies in Neurodegenerative Diseases
Eid, A. M., Faridar, A., & Appel, S. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_39 · Cited by 2
Mohebiany, A. N., & Waisman, A. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.001
Phillips, E. C. (2017) · Research Portal (King's College London)
The Neuroimmune Landscape of the Lysosomal Storage Disorder Sanfilippo Syndrome
Badell‐Grau, R. A., & Schlachetzki, J. C. M. (2025) · BioEssays · doi:10.1002/bies.70083 · Cited by 1
Woo, M. S., Nilsson, J., Therriault, J., Rahmouni, N., Brinkmalm, A., Benedet, A. L., Ashton, N. J., Macedo, A. C., Servaes, S., Wang, Y.-T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26645020
Muñoz‐Castro, C., Mejias‐Ortega, M., Sánchez‐Mejías, E., Navarro, V., Trujillo‐Estrada, L., Jiménez, S., León, J. A. G., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Romero‐Molina, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571967
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Role of T-cell immunity in the pathophysiology of Alzheimer’s disease and other Tauopathies
Matta, K. (2024) · theses.fr (ABES) · doi:10.70675/cea4fe5ez67c3z4445z92f7z39af62ba059b
Oon, C. H., Levitt, E. M., Shapiro, D. A., O’Brien, C. A., Davis, M. R., Shestova, O., Axsom, J., Yaqoob, F., Lomeikaitė, V., Koumadorakis, D., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10963419/v1
Metadata
- Authors
- Varvel, N. H., Grathwohl, S. A., Degenhardt, K., Resch, C., Bosch, A., Jucker, M., & Neher, J. J.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- Hertie Institute for Clinical Brain Research (DE)
- Corresponding author
- Neher, Jonas J.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2015-10-12
- Volume
- 212
- Issue
- 11
- Pages
- 1803-1809
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4612086
- OpenAlex
- W2217498682
- Cited by
- 99
- References
- 30
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 10 · 2023: 8 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 10 · 2018: 10 · 2017: 19 · 2016: 10 · 2015: 3
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DZNE Pub (submittedVersion)
- Funders
- Alzheimer's Association
- Alexander von Humboldt-Stiftung
- Universität Zürich
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- Alzheimer's disease, myeloid cells, peripheral blood monocytes, APP23 mice, APP/PS1 mice, amyloid plaques, TREM2, microglia
- MeSH terms
- Alzheimer Disease, Animals, Brain, Disease Models, Animal, Female, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Monocytes, Receptors, Immunologic, Amyloid beta-Peptides, Myeloid Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.